| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2024-09-10 19:47:36 UTC |
|---|
| Updated at | 2024-09-10 19:47:37 UTC |
|---|
| NP-MRD ID | NP0334747 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | Norbolethone |
|---|
| Description | Norbolethone, also known as 13-ehdpo or genabol, belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. It is reputed to have been the active ingredient in the original formulation of the "undetectable" steroid formulation known as "The Clear" before being replaced by the more potent drug tetrahydrogestrinone. Norbolethone is an extremely weak basic (essentially neutral) compound (based on its pKa). Norboletone (INN) (former proposed brand name Genabol), or norbolethone, is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed. The following year, Catlin identified and developed a test for tetrahydrogestrinone (THG), the second reported designer anabolic sample—a key development in the BALCO Affair. In the same year, U.S. Bicycle racer Tammy Thomas was caught using it and was banned from her sport. Norboletone is on the World Anti-Doping Agency's list of prohibited substances, and is therefore banned from use in most major sports. In 2002, Don Catlin, the founder and then-director of the UCLA Olympic Analytical Lab, identified norboletone for the first time in an athlete's urine sample. It was first developed in 1966 by Wyeth Laboratories and was investigated for use as an agent to encourage weight gain and for the treatment of short stature, but was never marketed commercially because of fears that it might be toxic. Norbolethone was first documented in 2002 (PMID: 12112254). It subsequently showed up in urine tests on athletes in competition in the early 2000s. |
|---|
| Structure | [H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] InChI=1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Norboletone | HMDB | | (+/-)-13,17a-diethyl-17b-hydroxygon-4-en-3-one | HMDB | | (+/-)-13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-3-one | HMDB | | (+/-)-13b,17a-diethyl-17b-hydroxygon-4-en-3-one | HMDB | | (+/-)-17a-ethyl-18-homo-19-nortestosterone | HMDB | | (17a)-(+/-)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-3-one | HMDB | | 13-Ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-3-one | HMDB | | DL-13,17a-Diethyl-17-hydroxygon-4-en-3-one | HMDB | | DL-13,17a-Diethyl-17b-hydroxygon-4-en-3-one | HMDB | | DL-17b-Hydroxy-13b,17a-diethylgon-4-en-3-one | HMDB | | DL-Norbolethone | HMDB | | Genabol | HMDB | | Wy 3475 | HMDB | | 13-EHDPO | HMDB | | 13-Ethyl-17-hydroxy-18,19-dinor-17-pregn-4-en-20-yn-3-one | HMDB |
|
|---|
| Chemical Formula | C21H32O2 |
|---|
| Average Mass | 316.4776 Da |
|---|
| Monoisotopic Mass | 316.24023 Da |
|---|
| IUPAC Name | (1S,2R,10R,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-5-one |
|---|
| Traditional Name | norbolethone |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@]12CC[C@@](O)(CC)[C@@]1(CC)CC[C@]1([H])[C@@]3([H])CCC(=O)C=C3CC[C@@]21[H] |
|---|
| InChI Identifier | InChI=1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1 |
|---|
| InChI Key | FTBJKONNNSKOLX-XUDSTZEESA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| Not Available | | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | Not Available |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as gluco/mineralocorticoids, progestogins and derivatives. These are steroids with a structure based on a hydroxylated prostane moiety. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Steroids and steroid derivatives |
|---|
| Sub Class | Pregnane steroids |
|---|
| Direct Parent | Gluco/mineralocorticoids, progestogins and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Progestogin-skeleton
- 3-oxo-delta-4-steroid
- 3-oxosteroid
- 17-hydroxysteroid
- Oxosteroid
- Hydroxysteroid
- Delta-4-steroid
- Cyclohexenone
- Cyclic alcohol
- Tertiary alcohol
- Cyclic ketone
- Ketone
- Organic oxygen compound
- Hydrocarbon derivative
- Carbonyl group
- Alcohol
- Organooxygen compound
- Organic oxide
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|